Biotech is going to be eaten by software, that's not in question. It's clear that Kleiner lost their first bet on health startups, which means that I'm looking forward to seeing the next batch of startups give it a go.
No doubt, biotech will be "eaten" by software. But the crowded market of biotech software has many viable open source alternatives. Besides, many tools have been developed or are being developed by established companies.
Yet, I don't see much evidence of growth. Looks like 'play money' for investors.
You could have said all these things about Dropbox.
"The crowded market of backup software has many viable open source alternatives. Besides, many tools have been developed or are being developed by established companies."
[+] [-] uams|12 years ago|reply
[+] [-] bonsai|12 years ago|reply
[+] [-] Irene|12 years ago|reply
Yet, I don't see much evidence of growth. Looks like 'play money' for investors.
[+] [-] rottencupcakes|12 years ago|reply
"The crowded market of backup software has many viable open source alternatives. Besides, many tools have been developed or are being developed by established companies."
[+] [-] liyanchang|12 years ago|reply